HOUSE_OVERSIGHT_026761.jpg
1.9 MB
Extraction Summary
14
People
18
Organizations
3
Locations
2
Events
8
Relationships
4
Quotes
Document Information
Type:
News article / printout
File Size:
1.9 MB
Summary
A Forbes article reporting on the Swedish American Life Science Summit (SALSS) in Stockholm, which gathered global scientists and investors to discuss innovations in healthcare such as robotics, nanotechnology, and cancer research. The article highlights the shift in the pharmaceutical industry towards collaboration with startups and "impact investing" to address chronic diseases in an aging population, featuring insights from various industry leaders.
Organizations (18)
Timeline (2 events)
Swedish American Life Science Summit (SALSS)
Moonshot cancer program
Relationships (8)
→
→
to
→
→
→
→
→
→
to
→
→
→
→
to
→
→
→
→
Key Quotes (4)
"So one of the major topics discussed at the SALSS conference was “impact investing,” or why investors should pay closer attention to investing in life science."Source
HOUSE_OVERSIGHT_026761.jpg
Quote #1
"“In today’s world with an aging population, we observe a higher occurrence of chronic diseases, such as cancer and autoimmune conditions,” noted Hans Straberg"Source
HOUSE_OVERSIGHT_026761.jpg
Quote #2
""Big Pharma is very much dependent on collaborating with them, or acquiring their technologies,” he argued."Source
HOUSE_OVERSIGHT_026761.jpg
Quote #3
"“Throughout the years, Swedish research and innovation have led the way to disruptive changes within medicine, which has resulted in an immense impact on people’s lives and great value for society,” argued Dr. Goran K. Hansson"Source
HOUSE_OVERSIGHT_026761.jpg
Quote #4
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document